| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/21/2011 | WO2010141833A3 Vital fluorochrome conjugates and methods of use |
| 04/21/2011 | WO2010135493A3 Alzheimer's disease imaging agents |
| 04/21/2011 | WO2010132474A3 Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields |
| 04/21/2011 | WO2010132471A3 Synthesis of stable elastomeric negative acoustic contrast particles |
| 04/21/2011 | US20110092926 Abuse potential reduction in abusable substance dosage form |
| 04/21/2011 | US20110092815 Marker or filler forming fluid |
| 04/21/2011 | US20110091390 Water soluble tetrapyrollic photosensitizers for photodynamic therapy |
| 04/21/2011 | US20110091389 Particles with radiation activated adhesive |
| 04/21/2011 | US20110091388 Use of pde7 inhibitors for the treatment of movement disorders |
| 04/21/2011 | US20110091387 Methods and compositions for reducing skin damage |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/21/2011 | US20110091384 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | US20110091376 Catatonic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| 04/21/2011 | US20110091374 Contrast agents for applications including perfusion imaging |
| 04/21/2011 | US20110091373 Paa nanoparticles for enhancement of tumor imaging |
| 04/21/2011 | US20110090316 Method and apparatus for 3-d imaging of internal light sources |
| 04/21/2011 | CA2776796A1 Porphyrin nanovesicles |
| 04/20/2011 | EP2311490A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/20/2011 | EP2311444A1 Method for preparing a stabilised menthol emulsion |
| 04/20/2011 | EP2310055A2 Novel method for measuring insulin resistance |
| 04/20/2011 | EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 04/20/2011 | CN1942430B 5-aminolevulinic acid phosphate, method for producing the same and use thereof |
| 04/20/2011 | CN102027019A High-density lipoprotein-like peptide-phospholipid scaffold (''HPPS'') nanoparticles |
| 04/20/2011 | CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis |
| 04/20/2011 | CN102026671A Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 04/20/2011 | CN102026668A Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 04/20/2011 | CN101612407B Polymer nanoparticle magnetic resonance contrast agent and preparing method thereof |
| 04/20/2011 | CN101574529B Application of near infrared fluorescent chemical in lymphaden imaging and angiogram |
| 04/19/2011 | US7928284 Methods and animal model for analyzing age-related macular degeneration |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927581 Peptide-based multimeric targeted contrast agents |
| 04/19/2011 | US7927580 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 04/19/2011 | US7927274 Integrated receiver for continuous analyte sensor |
| 04/14/2011 | WO2011044545A2 Methods and compositions for targeted imaging |
| 04/14/2011 | WO2011044377A2 Chelator-targeting ligand conjugates for cardiovascular imaging |
| 04/14/2011 | WO2011043980A1 Methods and compositions related to clot-binding lipid compounds |
| 04/14/2011 | WO2011043502A1 Composite of photosensitizer-metal nanoparticles and composition for photodynamic therapy or diagnosis comprising same |
| 04/14/2011 | WO2011043061A1 Contrast agent for photoacoustic imaging and photoacoustic imaging method utilizing same |
| 04/14/2011 | WO2011041894A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | US20110086915 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/14/2011 | US20110085987 Folic acid-mediated magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications |
| 04/14/2011 | US20110085986 Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides |
| 04/14/2011 | US20110085985 Novel substituted azabenzoxazoles |
| 04/14/2011 | US20110085984 Drug Product and Process for Making |
| 04/14/2011 | US20110085983 Liquid Chromatography-Mass Spectrometry Methods For Multiplexed Detection and Quantitation of Free Amino Acids |
| 04/14/2011 | US20110085982 Dkat cell line, a model for human triple-negative breast cancer |
| 04/14/2011 | US20110085981 Glycan-based drugs, therapies and biomarkers |
| 04/14/2011 | US20110085980 Cell cycle regulation and differentiation |
| 04/14/2011 | US20110085979 Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions |
| 04/14/2011 | US20110085978 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 04/14/2011 | US20110085977 Use of UTP for the diagnosis of stenoses and other conditions of restricted blood flow |
| 04/14/2011 | US20110085976 Methods for detecting cardiac damage |
| 04/14/2011 | US20110085974 Small molecule ligand-drug conjugates for targeted cancer therapy |
| 04/14/2011 | US20110085968 Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth |
| 04/14/2011 | CA2776583A1 Genetically modified mice and engraftment |
| 04/14/2011 | CA2775793A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | CA2775747A1 Methods and compositions related to clot-binding lipid compounds |
| 04/13/2011 | EP2308916A1 Polymer/metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 04/13/2011 | EP2308513A2 Fluorescent nanoparticles |
| 04/13/2011 | EP2308470A1 Sustained-release liposomal anesthetic compositions |
| 04/13/2011 | EP2308431A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 04/13/2011 | EP1998812B1 Method to assess surfactant adsorption on skin |
| 04/13/2011 | CN1840531B Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 04/13/2011 | CN1839806B Methods for in vivo delivery of biologics and compositions useful therefor |
| 04/13/2011 | CN1693415B Hydroxy phosphorite of near infrared fluorescence quantum point mark and its preparation process and application |
| 04/13/2011 | CN102014969A Contrast agents for applications including perfusion imaging |
| 04/13/2011 | CN102014968A Therapy selection method |
| 04/13/2011 | CN102014967A Use of pyrene to carry peptides across the blood brain barrier |
| 04/13/2011 | CN102014614A Animal model for diabetes |
| 04/13/2011 | CN102008736A Target cyclopeptide modified liposome microbubble and preparation method thereof |
| 04/13/2011 | CN102008441A Endoglin antibody coupled liposome as well as preparation method and application thereof |
| 04/13/2011 | CN101554481B Dual-functional imaging agent for SPECT and MRI and preparation method thereof |
| 04/13/2011 | CN101401943B Synthesis of oligomerized fragrant amide-containing paramagnetic metallo-chelates contrast medium |
| 04/12/2011 | US7925612 Method for graphically depicting drug adverse effect risks |
| 04/12/2011 | US7923210 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample |
| 04/12/2011 | US7923023 Method and composition for delivery of medicants to animals |
| 04/12/2011 | US7923001 Compositions and methods for diagnosing and treating urinary tract infections |
| 04/12/2011 | US7923000 Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| 04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 04/12/2011 | CA2185644C Use of green porphyrins in ocular diagnosis and therapy |
| 04/07/2011 | WO2011041701A2 Inplantable contrast agents and methods |
| 04/07/2011 | WO2011040574A1 Method for producing azetidinylmethoxypyridine derivative and use of azetidinylmethoxypyridine derivative |
| 04/07/2011 | WO2011039535A2 Micellar compositions for use in biological applications |
| 04/07/2011 | WO2011039244A1 Hydroxylated contrast enhancement agents and intermediates thereof |
| 04/07/2011 | WO2011015670A3 Metal oxide particles coated with polyethylene glycol and their synthesis |
| 04/07/2011 | WO2010078942A3 Dye solution |
| 04/07/2011 | US20110083200 Method For Testing Efficacy Of Treatment Of Neurologic Disorders |
| 04/07/2011 | US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules |
| 04/07/2011 | US20110081657 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/07/2011 | US20110081298 Ratiometric bioluminescent sensor for imagining oxidative stress |
| 04/07/2011 | US20110081297 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles |
| 04/07/2011 | US20110081296 Systems and methods for identification of ciliopathy therapeutics |
| 04/07/2011 | US20110081295 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration |
| 04/07/2011 | US20110081294 Contrast agent for photoacoustic imaging and photoacoustic imaging method |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/07/2011 | DE102009043717A1 Fluorcyclodextrine Fluorcyclodextrine |
| 04/06/2011 | EP2305316A2 Diphosphorylated glycopeptide imaging agent for fibrosis |
| 04/06/2011 | EP2305310A1 Gold -coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |